Although individual studies on the prognostic role of ER protein expression have previously resulted in conflicting outcomes, a recent meta-analysis concluded that OS was unrelated to ER protein expression in serous ovarian carcinoma (HR 0.90; 95%CI 0.75 to 1.08) [24,25,26,27]. The gene discussed is ESR1; the disease is ovarian serous carcinoma.